Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

WE Communications

- PMLiVE

Merck announces partnerships worth $1.3bn with BenevolentAI and Exscientia

The deals aim to accelerate drug development in oncology, neurology and immunology

- PMLiVE

BenevolentAI raises $115m to fund drug development

Its technology could cut the early stage drug discovery process by four years, says the company

BenevolentAI claims AI first with new Cambridge facility

Says its new drug discovery and development base will cover the entire research process

- PMLiVE

WE Communications wins BenevolentAI account

It will be tasked with raising the artificial intelligence firm's profile

- PMLiVE

BenevolentAI expands its reach opening an office in New York

The company hires Keith Hall and Daniel Neil to head up the new office

BenevolentAI appoints new head of cheminformatics

Dr Nathan Brown joins from the Institute of Cancer Research

- PMLiVE

Stephanie Marchesi joins WE Communications

Becomes president of agency’s US health business and East Coast presence

Artificial intelligence firm licenses Janssen candidates for development

UK-based BenevolentAI aims to move them into late-stage trials by mid-2017

- PMLiVE

Catherine Allen joins WE Communications

She becomes SVP and general manager of the agency's Boston office

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links